Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa
Clinical trial NCT01113281 · COMPLETED
Trial details
- NCT number
- NCT01113281
- Sponsor
- Serum Life Science Europe GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.